NCT07405164
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07405164
Title Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)
Acronym MK-6482-043/LITESPARK-043
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Merck Sharp & Dohme LLC
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
START San Antonio ( Site 0104) RECRUITING San Antonio Texas 78229 United States Details
Samsung Medical Center ( Site 2902) RECRUITING Gangnam Seoul 06351 South Korea Details
Severance Hospital, Yonsei University Health System ( Site 2901) RECRUITING Seodaemun-gu Seoul 03722 South Korea Details
Taipei Veterans General Hospital ( Site 2800) RECRUITING Taipei 11217 Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field